REQUEST A DEMO
Total
USD $0.00
Search more companies

"Novo Nordisk Pharmaceutical Services" Sp. z o.o. (Poland)

Main Activities: Scientific Research and Development Services
Full name: "Novo Nordisk Pharmaceutical Services" Sp. z o.o. Profile Updated: October 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

"Novo Nordisk Pharmaceutical Services" Sp. z o.o. is an enterprise based in Poland. Its main office is in Warsaw. The company operates in the Scientific Research and Development Services industry. It was established on September 12, 2002. "Novo Nordisk Pharmaceutical Services" Sp. z o.o. currently employs 101 - 250 (2015) people. The latest financial highlights indicate a net sales revenue increase of 50.56% in 2023. Its total assets grew by 55.92% over the same period. The net profit margin of "Novo Nordisk Pharmaceutical Services" Sp. z o.o. increased by 0.75% in 2023.

Headquarters
Ul. Krakowiakow 46
Warsaw; Mazowieckie; Postal Code: 02-255

Contact Details: Purchase the "Novo Nordisk Pharmaceutical Services" Sp. z o.o. report to view the information.

Website: http://www.novonordisk.com

Basic Information
Total Employees:
Purchase the "Novo Nordisk Pharmaceutical Services" Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the "Novo Nordisk Pharmaceutical Services" Sp. z o.o. report to view the information.
Registered Capital:
Purchase the "Novo Nordisk Pharmaceutical Services" Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the "Novo Nordisk Pharmaceutical Services" Sp. z o.o. report to view the information.
Incorporation Date:
September 12, 2002
Key Executives
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Proxy
Purchase this report to view the information.
Proxy
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
99.99%
Company Performance
Financial values in the chart are available after "Novo Nordisk Pharmaceutical Services" Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
50.56%
Total operating revenue
50.62%
Operating profit (EBIT)
195.29%
Net Profit (Loss) for the Period
187.7%
Total assets
55.92%
Total equity
38.3%
Operating Profit Margin (ROS)
1.03%
Net Profit Margin
0.75%
Return on Equity (ROE)
14.38%
Quick Ratio
0.12%
Cash Ratio
-0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?